uric acid has been researched along with HbS Disease in 38 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Excerpt | Relevance | Reference |
---|---|---|
" The mechanism of development of hyperuricemia (defined, serum uric acid (UA) ≥ 5." | 3.96 | Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients. ( Beach, I; Feig, D; Kaspar, CDW; Newlin, J; Sisler, I; Smith, W, 2020) |
"The mean eGFR was statistically significantly lower in patients with hyperuricemia than in those with normal uric acid levels (143 vs." | 3.85 | Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. ( Cutter, GR; Feig, DI; Howard, TH; Lebensburger, JD; Muntner, P, 2017) |
"Uric acid level was significantly increased in children with Hb-SS compared to corresponding values in control group (4." | 1.40 | Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings. ( Aloni, MN; Ekila, MB; Gini-Ehungu, JL; Lepira, FB; Ngiyulu, RM; Nseka, NM; Nsibu, CN, 2014) |
"Mean uric acid serum level was 281." | 1.38 | [Hyperuricemia in sickle cell disease in France]. ( Arlet, JB; Chatellier, G; Courbebaisse, M; de Montalembert, M; Pouchot, J; Prié, D; Ribeil, JA, 2012) |
"Patients with sickle cell anemia have various forms of renal dysfunction." | 1.31 | Renal function in children with sickle cell anemia. ( Aldudak, B; Anarat, A; Anarat, R; Bayazit, AK; Dikmen, N; Gali, E; Kilinç, Y; Noyan, A; Ozel, A, 2002) |
"Uric acid excretion was higher in the sicklers, and so was the mean urine acid to creatinine ratio (0." | 1.27 | Effect of dietary nitrogen on urinary excretion of non-protein nitrogen in adolescent sickle cell patients. ( Addae, SK; Apatu, RS; Odonkor, PO; Yamamoto, S, 1984) |
"Patients with sickle cell anemia were often normouricemic despite urate overproduction." | 1.26 | The natural history of urate overproduction in sickle cell anemia. ( Diamond, HS; Holden, D; Meisel, AD, 1979) |
"A nearly 72-old black male with sickle cell anemia suffered from heart failure, hypertension, chronic impaired kidney function with hyperuricemia and gout." | 1.25 | Long survival in sickle cell anemia. ( Huisman, TH; Sar, AV, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (60.53) | 18.7374 |
1990's | 4 (10.53) | 18.2507 |
2000's | 2 (5.26) | 29.6817 |
2010's | 8 (21.05) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Kaspar, CDW | 1 |
Beach, I | 1 |
Newlin, J | 1 |
Sisler, I | 1 |
Feig, D | 1 |
Smith, W | 1 |
Lebensburger, JD | 1 |
Cutter, GR | 1 |
Howard, TH | 1 |
Muntner, P | 1 |
Feig, DI | 1 |
Aloni, MN | 1 |
Ngiyulu, RM | 1 |
Gini-Ehungu, JL | 1 |
Nsibu, CN | 1 |
Ekila, MB | 1 |
Lepira, FB | 1 |
Nseka, NM | 1 |
Gupta, S | 1 |
Yui, JC | 1 |
Xu, D | 1 |
Fitzhugh, CD | 1 |
Clark, C | 1 |
Siddiqui, S | 1 |
Conrey, AK | 1 |
Kato, GJ | 2 |
Minniti, CP | 2 |
Castilhos, LG | 1 |
de Oliveira, JS | 1 |
Adefegha, SA | 1 |
Magni, LP | 1 |
Doleski, PH | 1 |
Abdalla, FH | 1 |
de Andrade, CM | 1 |
Leal, DBR | 1 |
Abhishek, K | 1 |
Sohail, M | 1 |
Kumar, R | 1 |
Patra, PK | 1 |
Choudhary, SB | 1 |
Taylor, JG | 1 |
Hildesheim, M | 1 |
O'Neal, P | 1 |
Wilson, J | 1 |
Castro, O | 1 |
Gordeuk, VR | 1 |
Cerqueira, BA | 1 |
Boas, WV | 1 |
Zanette, AD | 1 |
Reis, MG | 1 |
Goncalves, MS | 1 |
Arlet, JB | 1 |
Ribeil, JA | 1 |
Chatellier, G | 1 |
Pouchot, J | 1 |
de Montalembert, M | 1 |
Prié, D | 1 |
Courbebaisse, M | 1 |
Cumming, V | 1 |
Ali, S | 1 |
Forrester, T | 1 |
Roye-Green, K | 1 |
Reid, M | 1 |
Reynolds, MD | 1 |
Kaklamanis, P | 1 |
Adeyokunnu, AA | 1 |
Osanyintuyi, VO | 1 |
Morgan, AG | 2 |
De Ceulaer, K | 2 |
Serjeant, GR | 2 |
Isichei, UP | 1 |
Odonkor, PO | 1 |
Addae, SK | 1 |
Yamamoto, S | 1 |
Apatu, RS | 1 |
Choo-Kang, E | 1 |
Wilson, WA | 1 |
Diamond, HS | 4 |
Meisel, AD | 3 |
Holden, D | 4 |
al-Ali, AK | 1 |
Ahmed, MA | 1 |
Qaw, FS | 1 |
al-Fadel Saleh, M | 1 |
al-Bashir, A | 1 |
Nduka, N | 2 |
Kazem, Y | 1 |
Saleh, B | 1 |
Bayazit, AK | 1 |
Noyan, A | 1 |
Aldudak, B | 1 |
Ozel, A | 1 |
Anarat, A | 1 |
Kilinç, Y | 1 |
Gali, E | 1 |
Anarat, R | 1 |
Dikmen, N | 1 |
Meisel, A | 1 |
Sharon, E | 2 |
Cacatian, A | 2 |
Talbott, JH | 1 |
Gottlieb, N | 1 |
Grendelmeier, P | 1 |
Rodriguez, E | 1 |
Sar, AV | 1 |
Huisman, TH | 1 |
el-Hazmi, MA | 1 |
Warsy, AS | 1 |
Olukoga, AO | 1 |
Adewoye, HO | 1 |
Erasmus, RT | 1 |
Adedoyin, MA | 1 |
Adedeji, MO | 1 |
Ukoli, FA | 1 |
Omodiale, P | 1 |
Ekeke, GI | 1 |
Liu, TZ | 1 |
Buckalew, VM | 1 |
Someren, A | 1 |
Diamond, H | 1 |
Espinoza, LR | 1 |
Spilberg, I | 1 |
Osterland, CK | 1 |
Walker, BR | 1 |
Alexander, F | 1 |
Burkholder, GV | 1 |
Dotin, LN | 1 |
Thomason, WB | 1 |
Beach, PD | 1 |
McCollum, DE | 1 |
Mathews, RS | 1 |
O'NEIL, MT | 1 |
Gold, MS | 1 |
Williams, JC | 1 |
Spivack, M | 1 |
Grann, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease[NCT02373241] | Phase 2 | 1 participants (Actual) | Interventional | 2015-04-30 | Terminated (stopped due to Estimated GFR was determined not to be a reliable endpoint for this study. We identified significant variabilty in annual eGFR that it became inappropriate to randomize to a medication but use EGFR as the primary endpoint.) | ||
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients With Sickle Cell Anemia[NCT00011648] | 986 participants (Actual) | Observational | 2008-02-19 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"Outcome 1a. Document the rate of acceptance (quantitative) and reasons for acceptance/rejection (qualitative) in a randomized trial of trial of losartan for SCD patients with abnormal nocturnal blood pressures.~Outcome 1b. Identify the adherence rate to losartan during a randomized three year trial of losartan for SCD patients (n=40) with abnormal nocturnal blood pressure.~Outcome 1c. Determine the adherence rate to study procedures among participants enrolled in a three year trial of losartan for SCD patients (n=40) with abnormal nocturnal blood pressure." (NCT02373241)
Timeframe: 5 yrs
Intervention | Participants (Count of Participants) |
---|---|
Standard Blood Pressure Management | 0 |
Experimental Blood Pressure Management | 1 |
As a feasibility trial, the effect of losartan on lowering nocturnal hypertension will be monitored to identify the difference in nocturnal BP improvement between the two treatment arms, and within group standard deviation of BP (NCT02373241)
Timeframe: 5 years
Intervention | Participants (Count of Participants) |
---|---|
Experimental Blood Pressure Management | 1 |
We will prospectively evaluate the incidence of hypertension (Clinic BP in pts >5yrs and ABPM in pts >10 yrs) and role of blood and urine biomarkers (pts >5ys) among participants with HbSS or SB0 thalassemia (expected cohort n=200) over 5 yrs. We identified 20 participants (34%) with incident hypertension but randomized one to the study. The study was terminated as the eGFR was determined not to be a reliable endpoint in pediatric sickle cell. (NCT02373241)
Timeframe: 5 yrs
Intervention | Participants (Count of Participants) |
---|---|
Standard Blood Pressure Management | 0 |
Experimental Blood Pressure Management | 1 |
3 reviews available for uric acid and HbS Disease
Article | Year |
---|---|
Gout and hyperuricemia associated with sickle-cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arthritis; Female; Gout; Hemolysis; Humans; Male; Middle Age | 1983 |
Osteoarticular manifestations in sickle-cell disorders.
Topics: Anemia, Sickle Cell; Arterial Occlusive Diseases; Bone Diseases; Hemoglobin SC Disease; Humans; Join | 1984 |
Renal manifestations of sickle cell disease.
Topics: Acid-Base Equilibrium; Age Factors; Anemia, Sickle Cell; Capillaries; Dilatation; Erythrocytes, Abno | 1974 |
1 trial available for uric acid and HbS Disease
Article | Year |
---|---|
Laboratory and echocardiography markers in sickle cell patients with leg ulcers.
Topics: Adult; Age Factors; Anemia, Sickle Cell; Biomarkers; Body Mass Index; Cohort Studies; Echocardiograp | 2011 |
34 other studies available for uric acid and HbS Disease
Article | Year |
---|---|
Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.
Topics: Adolescent; Albuminuria; Anemia, Sickle Cell; Blood Transfusion; Child; Cohort Studies; Cross-Sectio | 2020 |
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Child | 2017 |
Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings.
Topics: Anemia, Sickle Cell; Blood Pressure; Child; Counseling; Creatinine; Democratic Republic of the Congo | 2014 |
Gout and sickle cell disease: not all pain is sickle cell pain.
Topics: Acute Disease; Adult; Age of Onset; Aged; Aged, 80 and over; Anemia, Sickle Cell; Female; Gout; Hemo | 2015 |
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Antioxidants; Catalase; Female; Glutathione; Humans; Hypoxanthine; Lipid | 2017 |
Mutation -538 T/C in bone morphogenetic protein 4 do not increase the risk in sickle-cell disease with orthopedic complications but strongly associated with increased LDH and uric acid level in Indian patients from Chhattisgarh and Jharkhand states.
Topics: Anemia, Sickle Cell; Bone Diseases; Bone Morphogenetic Protein 4; Calcium; Genotype; Hemoglobins; He | 2010 |
Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Cell Adhesion Molecules; Cross-Sectional Studies; Endotheliu | 2011 |
[Hyperuricemia in sickle cell disease in France].
Topics: Adolescent; Adult; Aged; Anemia, Sickle Cell; Female; France; Gout; Humans; Hyperuricemia; Male; Mid | 2012 |
Asymptomatic bacteriuria in sickle cell disease: a cross-sectional study.
Topics: Adult; Age Factors; Anemia, Sickle Cell; Bacteriuria; Cohort Studies; Cross-Sectional Studies; Femal | 2006 |
Serum uric acid status of Nigerian children with sickle cell disease.
Topics: Abdominal Neoplasms; Adolescent; Anemia, Sickle Cell; Burkitt Lymphoma; Child; Child, Preschool; Fem | 1984 |
Glomerular function and hyperuricaemia in sickle cell disease.
Topics: Adolescent; Adult; Aged; Anemia, Sickle Cell; Creatinine; Female; Humans; Kidney Function Tests; Kid | 1984 |
Hyperuricaemia in sickle cell disease.
Topics: Anemia, Sickle Cell; Child; Child, Preschool; Hematocrit; Humans; Infant; Nigeria; Uric Acid | 1984 |
Effect of dietary nitrogen on urinary excretion of non-protein nitrogen in adolescent sickle cell patients.
Topics: Adolescent; Ammonia; Anemia, Sickle Cell; Creatinine; Diet; Humans; Male; Nitrogen; Urea; Uric Acid | 1984 |
Serum urate concentrations in homozygous sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Child; Female; Humans; Male; Middle Aged; Sex Factors; Uric | 1981 |
The natural history of urate overproduction in sickle cell anemia.
Topics: Adolescent; Adult; Age Factors; Anemia, Sickle Cell; Child; Child, Preschool; Female; Glomerular Fil | 1980 |
Uric acid, creatinine and urea in normal, glucose-6-phosphate dehydrogenase-deficient and Hb SS Saudi subjects.
Topics: Anemia, Sickle Cell; Creatinine; Glucosephosphate Dehydrogenase Deficiency; Humans; Saudi Arabia; Si | 1995 |
Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bilirubin; Calcium; Child; Child, Preschool; Female; Hemoglo | 1995 |
Renal function in children with sickle cell anemia.
Topics: Anemia, Sickle Cell; Blood Urea Nitrogen; Child; Creatinine; Female; Glomerular Filtration Rate; Hum | 2002 |
The natural history of urate overproduction in sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Creatinine; Female; Humans; Male; Middle Aged; p-Aminohippur | 1979 |
Classification of uricosuric states based upon response to pharmacologic inhibitors of urate transport.
Topics: Anemia, Sickle Cell; Aspirin; Biological Transport; Diatrizoate; Fanconi Syndrome; Glomerular Filtra | 1977 |
Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia.
Topics: Adolescent; Adult; Aminohippuric Acids; Anemia, Sickle Cell; Biological Transport; Female; Glomerula | 1975 |
Gouty arthritis in the black race.
Topics: Adult; Aged; Anemia, Sickle Cell; Arthritis; Benzothiadiazines; Black People; Colchicine; Diuretics; | 1975 |
Long survival in sickle cell anemia.
Topics: Age Factors; Aged; Anemia, Aplastic; Anemia, Sickle Cell; Chronic Disease; Electrophoresis, Starch G | 1975 |
Triple alpha-genes (alpha alpha alpha anti3.7) in a patient with sickle cell anaemia.
Topics: Adolescent; Anemia, Sickle Cell; Bilirubin; Blood Proteins; Calcium; Cholesterol; Erythrocyte Count; | 1992 |
Maintenance of normouricaemia during adolescence in sickle-cell anaemia.
Topics: Adolescent; Age Factors; Anemia, Sickle Cell; Child; Female; Humans; Male; Sex Factors; Uric Acid | 1992 |
Hyperuricaemia and foetal haemoglobin levels in homozygous sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Female; Fetal Hemoglobin; Humans; Male; Middle Aged; Uric Ac | 1987 |
The antisickling role of uric acid in sickle cell disease.
Topics: Adolescent; Adult; Age Factors; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; E | 1987 |
Hyperuricemia associated with sickle-cell anemia may compensate for chronic antioxidant deficiency.
Topics: Adult; Anemia, Sickle Cell; Antioxidants; Erythrocytes; Female; Humans; Male; Uric Acid | 1986 |
Renal handling of uric acid in sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Urea Nitrogen; Creatinine; Female; Humans; Kidney Tubu | 1974 |
Joint manifestations of sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arthritis; Bone and Bones; Child; Child, Preschool; Erythroc | 1974 |
Uric acid excretion in sickle cell anemia.
Topics: Adolescent; Adult; Age Factors; Anemia, Sickle Cell; Creatinine; Female; Hemolysis; Humans; Lactates | 1971 |
Unexplained hematuria. How extensive should the evaluation be?
Topics: Anemia, Sickle Cell; Angiography; Arteriovenous Fistula; Biopsy; Cystoscopy; Glomerulonephritis; Hem | 1969 |
Aseptic necrosis of the femoral head: associated diseases and evaluation of treatment.
Topics: Adult; Age Factors; Anemia, Sickle Cell; Bone Diseases; Female; Femoral Fractures; Femur Head; Fluor | 1970 |
Sickle cell anemia and hyperuricemia.
Topics: Anemia, Sickle Cell; Erythropoiesis; Female; Gout; Humans; Middle Aged; Uric Acid | 1968 |